Výsledky vyhledávání - "O. O. Shakhmatova"

Akademický článek

Which scale is best to assess the risk of upper gastrointestinal bleeding in patients with stable coronary artery disease in the Russian population?

Autor: O. O. Shakhmatova, A. L. Komarov, U. P. Ergasheva, V. V. Korobkova, L. O. Minushkina, V. A. Brazhnik, D. A. Zateyshchikov, E. B. Yarovaya, E. P. Panchenko

Publikováno v: Кардиоваскулярная терапия и профилактика, Vol 23, Iss 4 (2024)

Aim. To evaluate and compare the prognostic value of various scales on the risk of upper gastrointestinal bleeding (GIB) in patients with stable coronary artery disease (CAD) in the Russian population.Material and methods. The study included patients

Externí odkaz: https://doaj.org/article/808641074deb4cc899ba2e5198914136

Zobrazit plný text záznamu

Akademický článek

Current views on antiplatelet therapy in acute coronary syndrome patients: the place of clopidogrel

Autor: O. O. Shakhmatova

Publikováno v: Атеротромбоз, Vol 12, Iss 1, Pp 30-45 (2022)

Clopidogrel is the most studied P2Y12 receptor blocker and still has no alternative in a number of categories of ACS patients in whom ticagrelor or prasugrel have not been studied or their use is associated with an unacceptably high risk of bleeding.

Externí odkaz: https://doaj.org/article/89835148cd1645c7b94ca5c728158c6e

Zobrazit plný text záznamu

Akademický článek

Cardiomyopathy and multiple arterial thrombosis in a patient with severe tachyform atrial fibrillation after COVID-19

Autor: O. O. Shakhmatova, E. P. Panchenko, T. V. Balakhonova, M. I. Makeev, V. M. Mironov, Z. N. Blankova, E. A. Butorova

Publikováno v: Атеротромбоз, Vol 0, Iss 1, Pp 6-24 (2021)

We present a case of cardiomyopathy with a reduced left ventricular ejection fraction of up to 18%, multivessel arterial thrombosis in a patient who had undergone severe COVID-19 3.5 months earlier. The cardiopathy was initially considered as an outc

Externí odkaz: https://doaj.org/article/958e9178500f46e9b72852759f9ff163

Zobrazit plný text záznamu

Akademický článek

The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation

Autor: O. O. Shakhmatova

Publikováno v: Атеротромбоз, Vol 0, Iss 2, Pp 28-43 (2020)

Edoxaban is a selective direct factor Xa inhibitor. Edoxaban in a dose of 60 mg per day is an effective and safe option in the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation, including in combination thera

Externí odkaz: https://doaj.org/article/7061fb27ad824f3b892cb503ba132cca

Zobrazit plný text záznamu

Akademický článek

Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy 'REGATТA' results)

Autor: O. O. Shakhmatova, A. L. Komarov, V. V. Korobkova, E. B. Yarovaya, M. V. Andreevskaya, A. G. Shuleshova, E. P. Panchenko

Publikováno v: Терапевтический архив, Vol 92, Iss 9, Pp 30-38 (2020)

Introduction.Upper gastrointestinal (UGI) bleeding is a common complication of antiplatelet therapy. Data from real clinical practice that characterize the range of risk factors for UGI bleeding, prophylactic proton pump inhibitors (PPIs) therapy, bl

Externí odkaz: https://doaj.org/article/195842b7477a434195e2c2af48384a43

Zobrazit plný text záznamu

Akademický článek

EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION

Autor: S. P. Golitsyn, E. P. Panchenko, E. S. Kropacheva, L. Yu. Layovich, E. B. Maikov, N. Yu. Mironov, O. O. Shakhmatova

Publikováno v: Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 4-85 (2019)

Externí odkaz: https://doaj.org/article/84663bffe54142379621feb27776db95

Zobrazit plný text záznamu

Akademický článek

Relationship between the D-dimer and von Willebrand factor levels and the development of gastrointestinal bleeding in patients with stable coronary artery disease: data from the registry of long-term antithrombotic therapy REGATTA-1

Autor: O. O. Shakhmatova, A. L. Komarov, V. V. Korobkova, E. V. Titaeva, A. B. Dobrovolskiy, E. B. Yarovaya, A. G. Shuleshova, E. P. Panchenko

Publikováno v: Кардиоваскулярная терапия и профилактика, Vol 20, Iss 7 (2021)

Aim. To study the role of von Willebrand factor (VWF) and D-dimer (DD) as predictors of upper gastrointestinal bleeding (GIB) in patients with stable coronary artery disease (CAD).Material and methods. The study included patients with stable CAD who

Externí odkaz: https://doaj.org/article/8aed6b76500049a496cd8219803d8124

Zobrazit plný text záznamu

Akademický článek

2020 Clinical guidelines for Atrial fibrillation and atrial flutter

Publikováno v: Российский кардиологический журнал, Vol 26, Iss 7 (2021)

Russian Society of Cardiology (RSC).With the participation of Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Cardiac Pacing, Russian Association of Cardiovascular Surgeons.Approved by the Scientific and Practical Council

Externí odkaz: https://doaj.org/article/bec19ff68992493eb9e972f8b2328631

Zobrazit plný text záznamu

Akademický článek

Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1

Autor: A. L. Komarov, O. O. Shakhmatova, V. V. Korobkova, E. S. Novikova, E. V. Guskova, E. B. Yarovaya, T. V. Balachonova, A. G. Shuleshova, E. P. Panchenko

Publikováno v: Российский кардиологический журнал, Vol 26, Iss 6 (2021)

Aim. To optimize the upper gastrointestinal bleeding (UGIB) risk scale in patients Material and methods. The UGIB risk scale was developed based on the with chronic coronary artery disease (CAD) receiving long-term antiplatelet therapy. prospective R

Externí odkaz: https://doaj.org/article/32e7c9cc69864dc6a0447b6048a7bdf7

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání